232 related articles for article (PubMed ID: 20645923)
1. Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
Lim NH; Kashiwagi M; Visse R; Jones J; Enghild JJ; Brew K; Nagase H
Biochem J; 2010 Oct; 431(1):113-22. PubMed ID: 20645923
[TBL] [Abstract][Full Text] [Related]
2. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
Troeberg L; Fushimi K; Khokha R; Emonard H; Ghosh P; Nagase H
FASEB J; 2008 Oct; 22(10):3515-24. PubMed ID: 18632849
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
Troeberg L; Fushimi K; Scilabra SD; Nakamura H; Dive V; Thøgersen IB; Enghild JJ; Nagase H
Matrix Biol; 2009 Oct; 28(8):463-9. PubMed ID: 19643179
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
5. TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.
Wang WM; Ge G; Lim NH; Nagase H; Greenspan DS
Biochem J; 2006 Sep; 398(3):515-9. PubMed ID: 16771712
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 antagonizes oncostatin M and transforming growth factor beta-induced responses in articular chondrocytes.
El Mabrouk M; Qureshi HY; Li WQ; Sylvester J; Zafarullah M
J Cell Biochem; 2008 Feb; 103(2):588-97. PubMed ID: 17546624
[TBL] [Abstract][Full Text] [Related]
7. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4.
Wayne GJ; Deng SJ; Amour A; Borman S; Matico R; Carter HL; Murphy G
J Biol Chem; 2007 Jul; 282(29):20991-8. PubMed ID: 17470431
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system.
Powell AJ; Little CB; Hughes CE
Arthritis Rheum; 2007 Sep; 56(9):3010-9. PubMed ID: 17763444
[TBL] [Abstract][Full Text] [Related]
9. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
Huang K; Wu LD
J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
[TBL] [Abstract][Full Text] [Related]
10. The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.
Moncada-Pazos A; Obaya AJ; Viloria CG; López-Otín C; Cal S
J Mol Med (Berl); 2011 Jun; 89(6):611-9. PubMed ID: 21365186
[TBL] [Abstract][Full Text] [Related]
11. Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.
Yamamoto K; Owen K; Parker AE; Scilabra SD; Dudhia J; Strickland DK; Troeberg L; Nagase H
J Biol Chem; 2014 Mar; 289(10):6462-6474. PubMed ID: 24474687
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
Lemke AK; Sandy JD; Voigt H; Dreier R; Lee JH; Grodzinsky AJ; Mentlein R; Fay J; Schünke M; Kurz B
Cell Tissue Res; 2010 Apr; 340(1):179-88. PubMed ID: 20217136
[TBL] [Abstract][Full Text] [Related]
13. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing aggrecan loss from aggrecan proteolysis in ADAMTS-4 and ADAMTS-5 single and double deficient mice.
Ilic MZ; East CJ; Rogerson FM; Fosang AJ; Handley CJ
J Biol Chem; 2007 Dec; 282(52):37420-8. PubMed ID: 17938173
[TBL] [Abstract][Full Text] [Related]
15. Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity.
Fushimi K; Troeberg L; Nakamura H; Lim NH; Nagase H
J Biol Chem; 2008 Mar; 283(11):6706-16. PubMed ID: 18156631
[TBL] [Abstract][Full Text] [Related]
16. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
Kashiwagi M; Enghild JJ; Gendron C; Hughes C; Caterson B; Itoh Y; Nagase H
J Biol Chem; 2004 Mar; 279(11):10109-19. PubMed ID: 14662755
[TBL] [Abstract][Full Text] [Related]
17. Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
Pattoli MA; MacMaster JF; Gregor KR; Burke JR
J Pharmacol Exp Ther; 2005 Oct; 315(1):382-8. PubMed ID: 16009742
[TBL] [Abstract][Full Text] [Related]
18. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term exposure of articular cartilage to curcumin or quercetin inhibits aggrecan loss.
Lay E; Samiric T; Handley CJ; Ilic MZ
J Nutr Biochem; 2012 Feb; 23(2):106-12. PubMed ID: 21419610
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of a disintegrin and metalloproteinase with thrombospondin motif 4 and 5 in osteoarthritis].
Ji Q; Zhang Q; Wang Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1080-4. PubMed ID: 24279019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
